Cardiovascular proteomics - Evolution and potential

被引:122
作者
Arrell, DK
Neverova, I
Van Eyk, JE
机构
[1] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
关键词
proteomics; protein modification; 2-D gel electrophoresis; mass spectrometry; cardiovascular disease; molecular mechanism;
D O I
10.1161/hh0801.090193
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of proteomics is a timely one for cardiovascular research. Analyses at the organ, subcellular, and molecular levels have revealed dynamic, complex, and subtle intracellular processes associated with heart and vascular disease. The power and flexibility of proteomic analyses, which facilitate protein separation, identification, and characterization, should hasten our understanding of these processes at the protein level. Properly applied, proteomics provides researchers with cellular protein "inventories" at specific moments in time, making it idea]. for documenting protein modification due to a particular disease, condition, or treatment. This is accomplished through the establishment of species- and tissue-specific protein databases, providing a foundation for subsequent proteomic studies. Evolution of proteomic techniques has permitted more thorough investigation into molecular mechanisms underlying cardiovascular disease, facilitating identification not only of modified proteins but also of the nature of their modification. Continued development should lead to functional proteomic studies, in which identification of protein modification, in conjunction with functional data from established biochemical and physiological methods, has the ability to further our understanding of the interplay between proteome change and cardiovascular disease.
引用
收藏
页码:763 / 773
页数:11
相关论文
共 136 条
[1]   An integrated approach to proteome analysis: Identification of proteins associated with cardiac hypertrophy [J].
Arnott, D ;
O'Connell, KL ;
King, KL ;
Stults, JT .
ANALYTICAL BIOCHEMISTRY, 1998, 258 (01) :1-18
[2]  
Arrell DK, 2000, CIRCULATION, V102, P202
[3]   A HUMAN MYOCARDIAL 2-DIMENSIONAL ELECTROPHORESIS DATABASE - PROTEIN CHARACTERIZATION BY MICROSEQUENCING AND IMMUNOBLOTTING [J].
BAKER, CS ;
CORBETT, JM ;
MAY, AJ ;
YACOUB, MH ;
DUNN, MJ .
ELECTROPHORESIS, 1992, 13 (9-10) :723-726
[4]   Proteomics: new perspectives, new biomedical opportunities [J].
Banks, RE ;
Dunn, MJ ;
Hochstrasser, DF ;
Sanchez, JC ;
Blackstock, W ;
Pappin, DJ ;
Selby, PJ .
LANCET, 2000, 356 (9243) :1749-1756
[5]   COMPARISON OF PROTEIN-ANALYSIS BETWEEN EMBRYONIC AND EXTRAEMBRYONIC TISSUES DURING THE 11TH DAY OF GESTATION OF THE MOUSE [J].
BAUMGARTNER, BG ;
MURACH, KF ;
SCHLEGEL, E ;
PRAXMAYER, C ;
ILLMENSEE, K .
ELECTROPHORESIS, 1994, 15 (07) :992-1000
[6]  
Berndt P, 1999, ELECTROPHORESIS, V20, P3521, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3521::AID-ELPS3521>3.0.CO
[7]  
2-8
[8]   Proteomics: quantitative and physical mapping of cellular proteins [J].
Blackstock, WP ;
Weir, MP .
TRENDS IN BIOTECHNOLOGY, 1999, 17 (03) :121-127
[9]   Sequence and structure-based prediction of eukaryotic protein phosphorylation sites [J].
Blom, N ;
Gammeltoft, S ;
Brunak, S .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) :1351-1362
[10]   Utility of accurate mass tags for proteome-wide protein identification [J].
Conrads, TP ;
Anderson, GA ;
Veenstra, TD ;
Pasa-Tolic, L ;
Smith, RD .
ANALYTICAL CHEMISTRY, 2000, 72 (14) :3349-3354